Skip to Content

Restructuring at Cactus Life Sciences: Oliver Dennis Named Chairman for Future Agency Vision

Founder’s Extensive Background in Healthcare Communications Complements Global Scientific Communications Agency’s Future Growth Strategy

PRINCETON, NJ / ACCESSWIRE / April 16, 2024 / Cactus Life Sciences, a prominent global scientific communications agency collaborating with top-tier pharmaceutical and biotechnology firms, has welcomed Oliver Dennis as Chairman to collaborate with co-founder Anurag Goel.

Oliver Dennis, Chairman of Cactus Life Sciences

Established in 2010 and headquartered in Princeton, New Jersey, Cactus Life Sciences is renowned for its innovative global operational frameworks that deliver cutting-edge scientific solutions and operational excellence. Anurag Goel expressed his enthusiasm about Oliver’s appointment, stating, “We are thrilled to have Oliver, whose extensive experience in business growth, especially in healthcare communications through founding Fishawack Health® (now Avalere®), will be invaluable to us.”

During his tenure at Fishawack, Oliver Dennis orchestrated the acquisition of 17 entities over 13 years, encompassing medical communications, branding agencies, strategic healthcare consultancies, and market access and HEOR advisory firms. Through four management buyouts, he steered the company’s expansion from a startup to a workforce of over 1,400 individuals across 22 offices worldwide, from San Diego to Singapore. Dennis is poised to shape Cactus Life Sciences’ future trajectory as the go-to healthcare communications agency of tomorrow, characterized by strategic agility, technological integration, and outcome-driven approaches, challenging conventional agencies that may have compromised flexibility and core identity for profit maximization. His primary focus will involve spearheading the inorganic growth strategy while fostering collaboration among diverse businesses and disciplines to enhance outcomes for clients, patients, and employees.

“I have closely monitored Cactus Life Sciences’ progress over the past decade, and I am thrilled to be part of their journey. Their consistent growth and ambition to disrupt the market as a next-generation challenger brand are truly inspiring,” remarked Dennis. “This presents an opportunity to prioritize addressing client needs, enhancing health outcomes, and nurturing our workforce.”

Elvira D’souza, President of Cactus Life Sciences, emphasized the importance of maintaining purpose, values, and individuality as the company evolves into a future-oriented agency. She highlighted the commitment to placing patients and employees at the forefront of all endeavors during the transformation process.

About Cactus Life Sciences

Cactus Life Sciences specializes in medical communication services, offering scientific strategies and content across the global healthcare landscape, emphasizing innovation, efficiency, and scientific rigor. Collaborating with leading healthcare enterprises, the company focuses on defining the optimal role of medications and promoting positive behaviors among physicians and patients to enhance patient outcomes. CACTUS maintains a presence in key locations such as Princeton, London, Aarhus, Singapore, Beijing, Shanghai, Seoul, Tokyo, and Mumbai.

Contact Information:

Laura Perry

Vice President of Strategy & Marketing


SOURCE: Cactus Life Sciences